Amyloidosis
Amyloidosis is caused by defective plasma cells producing too much protein. This abnormal protein build-up can affect the shape and function of organs like the heart, kidney, liver and spleen, in addition to the nervous and digestive systems. While there’s currently no cure for amyloidosis, several treatment options are available.
A rare disease, there are fewer than 200,000 cases of amyloidosis per year in the United States. If you are suffering from amyloidosis, talk to us. Our team of experts at City of Hope uses leading-edge methods to diagnose and treat this serious disease.
Amyloidosis is similar to myeloma, an uncommon cancer occurring in the plasma cells, so many of the same treatments used for myeloma are also used to treat amyloidosis.
As a founding member of the National Comprehensive Cancer Network, our doctors also help develop and improve evidence-based treatment guidelines for patients throughout the country.
The physicians in our Department of Hematology & Hematopoietic Cell Transplantation are leading experts in the field. They understand that a unique treatment plan tailored to the individual is critical to achieving the best possible outcomes.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Amyloidosis Care Team
City of Hope brings expert care to any hematologic malignancy.
